Published in Arch Dermatol on August 01, 1976
The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci (2011) 2.44
Acne, hormones, and treatment. Br Med J (Clin Res Ed) (1982) 1.06
Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands? Mol Vis (2009) 1.06
Acne vulgaris: pathogenesis and treatment. Br Med J (1980) 0.96
Influence of aromatase absence on the gene expression and histology of the mouse meibomian gland. Invest Ophthalmol Vis Sci (2013) 0.76
Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med (1979) 4.87
The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull (1974) 2.25
The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry (1974) 2.20
The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry (1987) 2.19
Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Arch Gen Psychiatry (1977) 1.81
The prediction of outcome in schizophrenia. I. Characteristics of outcome. Arch Gen Psychiatry (1972) 1.80
The course of psychiatric disorder, III: Longitudinal principles. Am J Psychiatry (1985) 1.80
The Vermont longitudinal study of persons with severe mental illness, I: Methodology, study sample, and overall status 32 years later. Am J Psychiatry (1987) 1.80
Intracutaneous injection of sebum and comedones. Histological observations. Arch Dermatol (1965) 1.77
Sustainable rates of sebum secretion in acne patients and matched normal control subjects. J Am Acad Dermatol (1983) 1.72
Sense of self in recovery from severe mental illness. Br J Med Psychol (1992) 1.71
Diagnostic criteria and five-year outcome in schizophrenia. A report from the International Pilot Study of schizophrenia. Arch Gen Psychiatry (1975) 1.70
Age-related changes in sebaceous gland activity. J Invest Dermatol (1979) 1.63
Effect of tetracycline on the composition of sebum in acne vulgaris. N Engl J Med (1965) 1.61
Hallucinations and delusions as points on continua function. Rating scale evidence. Arch Gen Psychiatry (1969) 1.59
Virtual microscopy: high resolution digital photomicrography as a tool for light microscopy simulation. Hum Pathol (1999) 1.54
Use of oral and topical agents for acne in pregnancy. J Am Acad Dermatol (1988) 1.47
Endocrinologic control of the development and activity of the human sebaceous gland. J Invest Dermatol (1974) 1.42
Anatomical variation in the amount and composition of human skin surface lipid. J Invest Dermatol (1970) 1.41
The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial. J Am Acad Dermatol (1980) 1.39
Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol (1984) 1.39
Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. Arch Gen Psychiatry (1973) 1.36
The effect of marked inhibition of sebum production with 13cis-retinoic acid on skin surface lipid composition. J Invest Dermatol (1980) 1.35
Chronicity in schizophrenia: revisited. Br J Psychiatry Suppl (1992) 1.32
Flexible system for the diagnosis of schizophrenia: report from the WHO International Pilot Study of Schizophrenia. Science (1973) 1.32
Cross-cultural evaluation of Schneider's first-rank symptoms of schizophrenia: a report from the International Pilot Study of Schizophrenia. Am J Psychiatry (1974) 1.23
Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol (1991) 1.22
Pyogenic granuloma-like acne lesions during isotretinoin therapy. Arch Dermatol (1983) 1.22
The composition of the ceramides from human stratum corneum and from comedones. J Invest Dermatol (1985) 1.21
Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol (1983) 1.19
An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. II. The relationship between schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry (1981) 1.14
The role of social relationships in the recovery from psychotic disorders. Am J Psychiatry (1984) 1.14
Chemical composition of human skin surface lipids from birth to puberty. J Invest Dermatol (1970) 1.14
Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. Arch Dermatol (1979) 1.12
Self-control in psychotic disorders. Arch Gen Psychiatry (1983) 1.10
Isotretinoin revisited. Cutis (1988) 1.08
Characteristic symptoms and outcome in schizophrenia. Arch Gen Psychiatry (1974) 1.08
Recent advances in androgen metabolism and their relation to the skin. Arch Dermatol (1969) 1.07
Variability in the chemical composition of human skin surface lipids. J Invest Dermatol (1969) 1.06
Beyond the biopsychosocial model: integrating disorder, health, and recovery. Psychiatry (1995) 1.03
Essential fatty acids and acne. J Am Acad Dermatol (1986) 1.03
Signs and symptoms as predictors of outcome: a report from the International Pilot Study of Schizophrenia. Am J Psychiatry (1978) 1.02
Effect of ethinyloestradiol on plasma testosterone levels and urinary testosterone excretion in man. Acta Endocrinol (Copenh) (1965) 1.02
Human stratum corneum polar lipids and desquamation. Arch Dermatol Res (1985) 1.01
The prediction of outcome in schizophrenia. IV: Eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis (1991) 1.01
Another view of schizophrenia subtypes. A report from the international pilot study of schizophrenia. Arch Gen Psychiatry (1976) 0.99
Effect of orally administered antibacterial agents on titratable acidity of human sebum. J Invest Dermatol (1966) 0.99
Sebaceous gland suppression with ethinyl estradiol and diethylstilbestrol. Arch Dermatol (1973) 0.98
The use of clustering techniques for the classification of psychiatric patients. Br J Psychiatry (1973) 0.98
Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol (1991) 0.98
Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. J Invest Dermatol (1976) 0.98
Topical clindamycin treatment of acne. Clinical, surface lipid composition, and quantitative surface microbiology response. Arch Dermatol (1980) 0.97
The effect of estrogen and androgen on the sebaceous gland turnover time. J Invest Dermatol (1969) 0.95
Effect of cyclic progestin-estrogen therapy on sebum and acne in women. JAMA (1980) 0.94
Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. J Am Acad Dermatol (1982) 0.93
Changes in long-term sebum production from isotretinoin therapy. J Am Acad Dermatol (1982) 0.93
Beyond diagnosis: the phenomenology of schizophrenia. Am J Psychiatry (1981) 0.93
Congenital neural hamartoma ("fascicular schwannoma"). A light microscopic, immunohistochemical, and ultrastructural study. Am J Dermatopathol (1990) 0.92
Effect of oral 13-cis-retinoic acid at three dose levels on sustainable rates of sebum secretion and on acne. J Am Acad Dermatol (1983) 0.92
Chronicity in schizophrenia: fact, partial fact, or artifact? Hosp Community Psychiatry (1987) 0.91
The sebaceous glands: twenty-five years of progress. J Invest Dermatol (1976) 0.91
The treatment of acute schizophrenia without drugs: an investigation of some current assumptions. Am J Psychiatry (1977) 0.91
Effect of prednisone on sebaceous gland secretion. J Invest Dermatol (1967) 0.90
Sebaceous gland response in man to the administration of testosterone, delta-4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol (1969) 0.90
New directions in diagnosis: the longitudinal processes of schizophrenia. Am J Psychiatry (1981) 0.89
The time course of lipid formation in human sebaceous glands. J Invest Dermatol (1977) 0.89
Premorbid adjustment in schizophrenia. Part II. Measuring premorbid adjustment: the instruments and their development. Schizophr Bull (1977) 0.88
Do psychiatric patients fit their diagnoses? Patterns of symptomatology as described with the biplot. J Nerv Ment Dis (1979) 0.88
Tretinoin emollient cream for photodamaged skin: results of 48-week, multicenter, double-blind studies. J Am Acad Dermatol (1997) 0.88
Work and mental illness. I. Toward an integration of the rehabilitation process. J Nerv Ment Dis (1987) 0.87
Effect of sequential mestranol-chlormadinone on sebum production. Arch Dermatol (1967) 0.87
Insight and interpretation of illness in recovery from psychosis. Schizophr Bull (1989) 0.87
A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat (2001) 0.86
The prognosis of schizophrenia: rationale for a multidimensional concept. Schizophr Bull (1978) 0.86
The effect of accumulated lipids on measurements of sebum secretion in human skin. J Invest Dermatol (1982) 0.86
Diagnostic models and the nature of psychiatric disorder. Arch Gen Psychiatry (1973) 0.86
Sebaceous gland response in man to prolonged total caloric deprivation. J Invest Dermatol (1970) 0.86